The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies
Abstract
The clinical and laboratory phenotype of a paraproteinaemic neuropathy syndrome termed chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies is described in a series of 18 cases. Previous single case reports have outlined some features of this syndrome. All 18 cases were defined by the presence of serum IgM antibodies which react principally with NeuAc (alpha2-8)NeuAc(alpha2-3)Gal-configured disialosyl epitopes common to many gangliosides including GDlb, GD3, GTlb and GQlb. In 17 out of 18 cases, the serum contained benign IgM paraproteins, and in four of these cases at least two IgM paraproteins were present. The IgM antibodies were also cold agglutinins in 50% of cases. The clinical picture comprised a chronic neuropathy with marked sensory ataxia and areflexia, and with relatively preserved motor function in the limbs. In addition, 16 out of 18 cases had motor weakness affecting oculomotor and bulbar muscles as fixed or as relapsing-remitting features. When present in their entirety, these clinical features have been described previously under the acronym CANOMAD: chronic ataxic neuropathy, ophthalmoplegia, IgM paraprotein, cold agglutinins and disialosyl antibodies. This distribution of clinical features is reminiscent of Miller Fisher syndrome, in which acute-phase anti-disialylated ganglioside IgG antibodies are found. Clinical electrophysiology and nerve biopsy show both demyelinating and axonal features. A partial response to intravenous immunoglobulin and other treatments is reported in some cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
Chiba, A., Kusunoki, S., Shimizu, T., & Kanazawa, I. (1992) · Annals of Neurology · doi:10.1002/ana.410310619 · Cited by 562
Leger, J.-M., Chassande, B., Musset, L., Meininger, V., Bouche, P., & Baumann, N. (2001) · Brain · doi:10.1093/brain/124.1.145 · Cited by 279
Goodyear, C. S., O’Hanlon, G. M., Plomp, J. J., Wagner, E. R., Morrison, I., Veitch, J., Cochrane, L., Bullens, R. W. M., Molenaar, P. C., Conner, J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6837 · Cited by 210
Self-citationExperimental sensory neuropathy induced by sensitization with ganglioside GD1b
Kusunoki, S., Shimizu, J., Chiba, A., Ugawa, Y., Hitoshi, S., & Kanazawa, I. (1996) · Annals of Neurology · doi:10.1002/ana.410390404 · Cited by 199
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates
Plomp, J. J., Molenaar, P. C., O'Hanlon, G. M., Jacobs, B. C., Veitch, J., Daha, M. R., Van Doorn, P. A., Van Der Mech�, F. G. A., Vincent, A., Morgan, B. P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<189::aid-ana9>3.0.co;2-t · Cited by 196
Self-citationChassande, B., L�ger, J.-M., Younes-Chennoufi, A. B., Bengoufa, D., Maisonobe, T., Bouche, P., & Baumann, N. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199801)21:1<55::aid-mus8>3.0.co;2-f · Cited by 184
Ilyas, A. A., Quarles, R. H., Dalakas, M. C., Fishman, P. H., & Brady, R. O. (1985) · Annals of Neurology · doi:10.1002/ana.410180605 · Cited by 184
Invited review: Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies
Md, A. P. (1991) · Muscle & Nerve · doi:10.1002/mus.880141002 · Cited by 171
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release
Roberts, M. T. M., Vincent, A. C., Newsom–Davis, J., & Willison, H. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92694-8 · Cited by 151
Self-citationThe immunopathogenesis of Miller Fisher syndrome.
Willison, H., & O'Hanlon, G. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00213-1 · Cited by 149
Self-citation
Cited by
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Self-citationChronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
Mathey, E. K., Park, S. B., Hughes, R. A. C., Pollard, J. D., Armati, P. J., Barnett, M. H., Taylor, B. V., Dyck, P. J. B., Kiernan, M. C., & Lin, C. S.-Y. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309697 · Cited by 440
Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications
Fermand, J.-P., Bridoux, F., Dispenzieri, A., Jaccard, A., Kyle, R. A., Leung, N., & Merlini, G. (2018) · Blood · doi:10.1182/blood-2018-04-839480 · Cited by 299
Metadata
- Authors
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-10-01
- Volume
- 124
- Issue
- 10
- Pages
- 1968-1977
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2102906003
- Cited by
- 297
- References
- 31
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. https://app.cochat.ai/papers/10.1093/brain/124.10.1968
- The paper
- Willison, H. J. (2001). The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain. https://doi.org/10.1093/brain/124.10.1968
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.